A phase I study of q3W R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors
Year: 2007
Type: article
Study design: Clinical Trial
Source: Molecular Cancer Therapeutics
Institution: Rutgers Cancer Institute
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2264947172
